Products
Research study
28-Feb-2013 -
Traditionally, HPMC capsules have been formulated with secondary gelling agents and ionic gel promoters, which may lead to unwanted issues during the product development.Vcaps® Plus HPMC capsules are made through a proprietary manufacturing process that eliminates the need for gelling...
Case study
04-Feb-2013 -
Is your drug active susceptible to amine oxidation? Croda’s Super Refined Propylene Glycol was shown to prevent N-Oxidation and improve drug stability, as compared to standard compendial grade Propylene Glycol USP.
Insight guide
05-Dec-2012 -
Pharmaceutical drug product development can be an expensive and time consuming process. Many challenges are faced by pharmaceutical development companies including developing a scaleable, marketable formulation, ensuring safety and efficacy of the drug product and receiving approval of the drug...
Video
24-Sep-2012 -
Capsugel is a global leader in innovative dosage solutions for Healthcare. Visit Capsugel at ICSE – Oct 9-11 and AAPS Oct 14-18 .The experience at Capsugel’s booth will feature proprietary market research and the latest capsule technology
Data sheet
10-Sep-2012 -
Maximize your drug active and overall formulation stability with high purity PEG 400. Croda’s Super Refined® PEG 400 has demonstrated it improves API stability as well as reduces gelatin cross-linking.
On-Demand Supplier Webinar
09-Aug-2012 -
This webinar will discuss development of design spaces for lyophilized pharmaceutical products in the context of the Quality by Design regulatory paradigm. Steven Nail, PhD, principal scientist at Baxter’s Lyophilization Center of Excellence with extensive expertise in the field, presents...
Data sheet
06-Aug-2012 -
API bioavailability can be optimized through enhancing the stability of your API itself and by improving overall oxidative stability of your formulation. Croda’s Super Refined Oils have demonstrated these benefits. Fill the form for more information.